Foundation For Disease Elimination And Control Of India Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -67.17%
(FY 2023)
- Profit -26.58%
(FY 2023)
- Ebitda 57.98%
(FY 2023)
- Net Worth -140.27%
(FY 2023)
- Total Assets -5.21%
(FY 2023)
About Foundation For Disease Elimination And Control Of India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Azadar Khan, Nirmal Ganguly, Yogendra Gupta, and One other member serve as directors at the Company.
- CIN/LLPIN
U85190MH2016NPL286097
- Company No.
286097
- Company Classification
Public Not For Profit Company
- Incorporation Date
21 Sep 2016
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Foundation For Disease Elimination And Control Of India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Azadar Khan  | Director | 21-Sep-2016 | Current |
| Nirmal Ganguly | Additional Director | 29-Feb-2024 | Current |
| Yogendra Gupta | Director | 04-Aug-2018 | Current |
Altaf Lal  | Director | 07-Feb-2017 | Current |
Financial Performance and Corporate Structure Insights of Foundation For Disease Elimination And Control Of India.
Foundation For Disease Elimination And Control Of India, for the financial year ended 2023, experienced significant reduction in revenue, with a 67.17% decrease. The company also saw a substantial fall in profitability, with a 26.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 140.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Foundation For Disease Elimination And Control Of India?
In 2023, Foundation For Disease Elimination And Control Of India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bharat Immunologicals And Biologicals Corporation LimitedActive 35 years 9 monthsYogendra Gupta is a mutual person
Sicuremi Healthcare Technologies Private LimitedActive 6 years 7 monthsYogendra Gupta is a mutual person
Pushpawati Singhania Hospital & Research InstituteActive 29 years 5 monthsNirmal Ganguly is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Foundation For Disease Elimination And Control Of India?
Unlock and access historical data on people associated with Foundation For Disease Elimination And Control Of India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Foundation For Disease Elimination And Control Of India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Foundation For Disease Elimination And Control Of India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
